Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Neuropeptides
- Vol. 12 (3) , 119-124
- https://doi.org/10.1016/0143-4179(88)90041-8
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Regional Distribution of Immunoreactive-Thyrotrophin-Releasing Hormone and Substance P, and Indoleamines in Human Spinal CordJournal of Neurochemistry, 2006
- Substance P and somatostatin modulate spinal cord excitability via physiologically different sensory pathwaysBrain Research, 1986
- Substance P, enkephalins, somatostatin, cholecystokinin, oxytocin, and vasopressin in human spinal cordNeurology, 1985
- The regional distribution of somatostatin, substance P and neurotensin in human brainBrain Research, 1981
- Behavioral evidence that substance P may be a spinal cord sensory neurotransmitterBrain Research, 1981
- Dual Actions of Substance P on Nociception: Possible Role of Endogenous OpioidsScience, 1978
- Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the ratNeuroscience, 1976
- Substance P: Localization in the Central Nervous System and in Some Primary Sensory NeuronsScience, 1975
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973
- Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1Endocrinology, 1968